Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATCAY | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | SYAP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | RP11-216L13.16 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | RBM10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | TSPEAR | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | BTN1A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ARHGAP39 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | CHADL | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | TNRC6C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |